| Literature DB >> 32266100 |
Jing Sun1, Dawei Meng2, Tao Yu3, Feng Li4,5, Guirong Zhang1, Xin Tian6, Nannan Zhao3, Guimin Li2, Lu Li7, Hongyue Wang8, Yeqiu Liu3, Yiming Meng1, Yushu Ma1, Zhong Wan8, Jimin Bao2, Haozhe Piao1,9.
Abstract
The N-terminal truncated carboxypeptidase E (CPEΔN) protein, an alternative splicing product of the carboxypeptidase E gene, has recently been recognized as an independent predictor for the recurrence and metastasis of lung adenocarcinoma. In this study, we showed that CPEΔN may accelerate lung cancer invasion via an E-cadherin-dependent mechanism. In vitro experiments and in vivo bioluminescence imaging assay revealed CPEΔN promoted the mobility and invasion of human lung cancer cells by suppressing endogenous expression of E-cadherin, a critical regulator for epithelial tissue homeostasis. Further mechanistic analyses revealed that CPEΔN directly interacted with and stabilized the Snail/HDAC1/HDAC3 complex within the promoter region of the E-cadherin-encoding CDH1 gene. CPEΔN overexpression led to a reduction of histone H3K9 acetylation and an increase of H3K9 and H3K27 trimethylation in the CHD1 gene promoter and ultimately inhibited E-cadherin transcription. In addition, correlations among CPEΔN, E-cadherin expression and tumor progression in 195 cases of lung adenocarcinoma patients were analyzed. Higher nuclear expression of CPEΔN was detected in patients with advanced stage of lung adenocarcinoma. Nuclear expression of CPEΔN was negatively correlated with the cell membrane expression of E-cadherin. Collectively, our findings illustrated that CPEΔN was involved in the transcriptional regulation of the epithelial-mesenchymal transition-related gene CDH1 and provide novel insights into CPEΔN-associated lung cancer metastasis. AJCREntities:
Keywords: E-cadherin; N-terminal truncated carboxypeptidase E; Snail/HDAC1/HDAC3 complex; epigenetic modification; epithelial-mesenchymal transition; lung adenocarcinoma; metastasis; recurrence; transcription regulation
Year: 2020 PMID: 32266100 PMCID: PMC7136916
Source DB: PubMed Journal: Am J Cancer Res ISSN: 2156-6976 Impact factor: 6.166